Helix BioPharma Earnings Estimate

HBP Stock  CAD 0.87  0.04  4.82%   
By analyzing Helix BioPharma's earnings estimates, investors can diagnose different trends across Helix BioPharma's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Helix BioPharma Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Helix BioPharma is projected to generate 0.0 in earnings per share on the 31st of July 2022. Helix BioPharma earnings estimates show analyst consensus about projected Helix BioPharma Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Helix BioPharma's historical volatility. Many public companies, such as Helix BioPharma, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Helix BioPharma's earnings estimates, investors can diagnose different trends across Helix BioPharma's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 2nd of December 2024, Gross Profit Margin is likely to grow to 0.69, though Gross Profit is likely to grow to (13.3 K).
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helix BioPharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Helix BioPharma Earnings per Share Projection vs Actual

About Helix BioPharma Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Helix BioPharma earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Helix BioPharma estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Helix BioPharma fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-210.7 M-221.2 M
Earnings Yield(0.18)(0.19)
Price Earnings Ratio(5.52)(5.80)
Price Earnings To Growth Ratio(0.19)(0.18)

Pair Trading with Helix BioPharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Helix BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Helix Stock

  0.83GOOG Alphabet CDRPairCorr
  0.81AMZN Amazon CDRPairCorr
  0.81BOFA Bank of AmericaPairCorr
  0.8JPM JPMorgan ChasePairCorr
  0.79NVDA NVIDIA CDRPairCorr
The ability to find closely correlated positions to Helix BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Helix BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Helix BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Helix BioPharma Corp to buy it.
The correlation of Helix BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Helix BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Helix BioPharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Helix BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Helix Stock

Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.